Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood.

× No keyword cloud information.

11 in total

1. The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome.

Authors: Laura Lahdentausta; Timo Sorsa; Erkki Pesonen; Pirkko Pussinen
Journal: J Cardiovasc Transl Res Date: 2018-09-24 Impact factor: 4.132

Review 2. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic kidney disease and acute kidney injury: a systematic review of the literature.

Authors: C L Sampieri; R A Orozco-Ortega
Journal: Hippokratia Date: 2018 Jul-Sep Impact factor: 0.471

Review 3. Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection.

Authors: Joel A Mathews; Yan G Ni; Connie Wang; Jon E Peterson; Chad Ray; Xuemei Zhao; Daoyu Duan; Sara Hamon; John Allinson; Martha Hokom; Greta Wegner
Journal: AAPS J Date: 2020-01-29 Impact factor: 4.009

Review 4. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.

Authors: Roopali Roy; Jiang Yang; Marsha A Moses
Journal: J Clin Oncol Date: 2009-09-08 Impact factor: 44.544

5. Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Authors: Christian G Sauer; Alexandra Kappeler; Monika Späth; Jens J Kaden; Maurice S Michel; Doris Mayer; Uwe Bleyl; Rainer Grobholz
Journal: Virchows Arch Date: 2004-04-16 Impact factor: 4.064

6. The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients.

Authors: Kuvaja Paula; Talvensaari-Mattila Anne; Turpeenniemi-Hujanen Taina
Journal: Biomark Insights Date: 2007-04-03

7. Reappraisal of quantitative gel zymography for matrix metalloproteinases.

Authors: Tommaso Prescimone; Danika Tognotti; Chiara Caselli; Manuela Cabiati; Andrea D'Amico; Silvia Del Ry; Daniela Giannessi
Journal: J Clin Lab Anal Date: 2014-03-19 Impact factor: 2.352

8. Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy.

Authors: K Jung
Journal: Br J Cancer Date: 2008-07-22 Impact factor: 7.640

9. Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population.

Authors: Peter Garvin; Lena Jonasson; Lennart Nilsson; Magnus Falk; Margareta Kristenson
Journal: PLoS One Date: 2015-09-21 Impact factor: 3.240

Review 10. Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review.

Authors: Andreas Kousios; Panayiotis Kouis; Andrie G Panayiotou
Journal: Int J Nephrol Date: 2016-03-02